C07C255/38

CRYSTALLINE FORMS OF DELTAMETHRIN AND METHODS OF USE THEREOF

The present invention relates to a novel crystalline form of deltamethrin, which is a pyrethroid compound useful as a pest control agent. The present invention further relates to a process of preparing the novel crystalline form, and to methods of controlling pests using the novel crystalline form.

CRYSTALLINE FORMS OF DELTAMETHRIN AND METHODS OF USE THEREOF

The present invention relates to a novel crystalline form of deltamethrin, which is a pyrethroid compound useful as a pest control agent. The present invention further relates to a process of preparing the novel crystalline form, and to methods of controlling pests using the novel crystalline form.

Crystalline forms of deltamethrin and methods of use thereof

The present invention relates to a novel crystalline form of deltamethrin, which is a pyrethroid compound useful as a pest control agent. The present invention further relates to a process of preparing the novel crystalline form, and to methods of controlling pests using the novel crystalline form.

Crystalline forms of deltamethrin and methods of use thereof

The present invention relates to a novel crystalline form of deltamethrin, which is a pyrethroid compound useful as a pest control agent. The present invention further relates to a process of preparing the novel crystalline form, and to methods of controlling pests using the novel crystalline form.

PROCESS FOR THE PRODUCTION OF ANTITUMOUR PHARMACEUTICAL COMPOSITIONS USING PUSH-PULL BUTADIENES, COMPOUNDS AND USES THEREOF

The present invention reports the obtaining of carbonyl compounds and derivatives, through syntheses with high yield and purity, providing anti-humoral active principles with selective antiproliferative properties and anti-metastatic activity.

The present invention refers to the development of new polyfunctional push-pull butadienes and their O and C-prenylated, benzoylated and iodide derivatives, with high electronic conjugation in the lateral chain. These compounds exhibit high anti-tumor selectivity, causing cell death by apoptosis, also show anti-metastatic and non-mutagenic properties in the experimental studies performed.

PROCESS FOR THE PRODUCTION OF ANTITUMOUR PHARMACEUTICAL COMPOSITIONS USING PUSH-PULL BUTADIENES, COMPOUNDS AND USES THEREOF

The present invention reports the obtaining of carbonyl compounds and derivatives, through syntheses with high yield and purity, providing anti-humoral active principles with selective antiproliferative properties and anti-metastatic activity.

The present invention refers to the development of new polyfunctional push-pull butadienes and their O and C-prenylated, benzoylated and iodide derivatives, with high electronic conjugation in the lateral chain. These compounds exhibit high anti-tumor selectivity, causing cell death by apoptosis, also show anti-metastatic and non-mutagenic properties in the experimental studies performed.

Active-energy-ray-curable composition, active-energy-ray-curable ink, ink stored container, ink ejecting device, method for forming image, and image
09796862 · 2017-10-24 · ·

To provide an active-energy-ray-curable composition including: a (meth)acrylic acid ester compound represented by General Formula (1) below, ##STR00001##
where in the General Formula (1), R.sub.1 represents a hydrogen atom or a methyl group, R.sub.2 represents a hydrogen atom, an alkyl group having from 1 through 5 carbon atoms, or an alkyloxy group having from 1 through 5 carbon atoms, n is an integer of from 0 through 5, and X represents an electron-withdrawing functional group.

Active-energy-ray-curable composition, active-energy-ray-curable ink, ink stored container, ink ejecting device, method for forming image, and image
09796862 · 2017-10-24 · ·

To provide an active-energy-ray-curable composition including: a (meth)acrylic acid ester compound represented by General Formula (1) below, ##STR00001##
where in the General Formula (1), R.sub.1 represents a hydrogen atom or a methyl group, R.sub.2 represents a hydrogen atom, an alkyl group having from 1 through 5 carbon atoms, or an alkyloxy group having from 1 through 5 carbon atoms, n is an integer of from 0 through 5, and X represents an electron-withdrawing functional group.

HNQO1-ACTIVATABLE FLUORESCENT PROBE FOR IMAGING CANCER CELLS IN-VITRO AND IN-VIVO
20210154330 · 2021-05-27 ·

The present invention includes a probe, an assay, a method of detecting, a human NAD(P)H quinone oxidoreductase-1 (hNQO1) enzyme activity with a fluorescent probe comprising a quinone propionic acid (QPA) conjugated to dicyanoisophorone (DCP), wherein the hNQO1 reduces the probe to releases a fluorescent DCP, and a method of making the same.

HNQO1-ACTIVATABLE FLUORESCENT PROBE FOR IMAGING CANCER CELLS IN-VITRO AND IN-VIVO
20210154330 · 2021-05-27 ·

The present invention includes a probe, an assay, a method of detecting, a human NAD(P)H quinone oxidoreductase-1 (hNQO1) enzyme activity with a fluorescent probe comprising a quinone propionic acid (QPA) conjugated to dicyanoisophorone (DCP), wherein the hNQO1 reduces the probe to releases a fluorescent DCP, and a method of making the same.